Joern-peter Halle PhD

Joern-Peter Halle, PhD, is leading the Translational Innovation Platform Immuno-Oncology of EMD Serono, known outside of the US as Merck KGaA, Darmstadt, Germany, with global responsibility for the research, discovery, and translational aspects of EMD Serono’s IO portfolio. As the global head for External Innovation he oversees the search & evaluation of external opportunities in all therapeutic areas ranging from academic collaborations to clinical assets. He is also responsible for innovation initiatives of the healthcare business and a member of the investment committee of EMD Serono’s corporate venture fund.

Most recently, he was Head of the President’s Office and of Strategy and Business operations in healthcare. Prior to this, he was responsible for the program leaders of the clinical oncology portfolio and Head of Early Stage Licensing. He started his carrier in EMD 12 years ago as a member of the corporate development team and was member of the Serono acquisition and integration team. Prior to joining EMD, he co-founded a biotech company focusing on R&D in dermatology where he was responsible for IP, bioinformatics, and technology development and served as a Chief Business Officer.